Document is current
Any future updates will be listed below
-
Authors
Müller, Katharina J. https://orcid.org/0000-0001-7098-4744
Stürzl, Roman
Kirchleitner, Sabrina
von Polenz, Isabelle
Ruf, Viktoria
Stoecklein, Veit M.
Reis, Jonas https://orcid.org/0000-0001-8932-2265
Quach, Stefanie
Kaiser, Lena
Lorenz, Julia
Zounek, Adrian
Harter, Patrick N.
Rupprecht, Rainer
Riemenschneider, Markus J.
Brendel, Matthias
Thon, Niklas
Tonn, Joerg-Christian https://orcid.org/0009-0004-1756-423X
von Baumgarten, Louisa https://orcid.org/0000-0002-6634-0927
Albert, Nathalie L. https://orcid.org/0000-0003-0953-7624
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 6 January 2026
Accepted: 7 May 2026
First Online: 30 May 2026
Declarations
Ethics approval and consent to participate: The study received approval from the ethical review board of LMU (approval no. 18–783 and 17–656) and was conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent prior to each [ 18 F]FET-PET/CT scan which was performed as part of clinical routine.
Consent for publication: The patient provided written informed consent to publication of this report.
Conflict of interest: KJM received grant support by the Friedrich-Baur-Stiftung and the Deutsche Forschungsgemeinschaft (DFG - German Research Foundation).LvB has received honoraria for lectures, consultation or advisory board participation from Servier, Merck and research funding from Novocure.NLA has received honoraria for lectures, consultation or advisory board participation from Novartis / Advanced Accelerator Applications, ABX, ITM Oncologics GmbH, Carthera, OncLive, Medsir, Telix Pharmaceuticals and Servier and research funding from Novocure, Telix Pharmaceuticals and Servier.JCT has received honoraria for consultation or advisory board participation from Servier, Carthera and ERCM.MB received speaker honoraria from GE healthcare, Roche, and Life Molecular Imaging and advised GE healthcare, MIAC, and Life Molecular Imaging.VR received speaker honoraria from Novocure.
